A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and SafetyStudy of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)

  • Kim, Hyun (PI)

Project: Research project

Project Details

Description

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
StatusActive
Effective start/end date11/1/1911/1/21

Funding

  • FIBROGEN, INC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.